IIM
GLUE icon

INTECH Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History

INTECH Investment Management’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Sell
13,883
-4,995
-26% -$94.4K ﹤0.01% 1525
2026
Q1 		$311K Sell
18,878
-514
-3% -$9.83K ﹤0.01% 1560
2025
Q4 		$304K Buy
19,392
+5,987
+45% +$80.7K ﹤0.01% 1759
2025
Q3 		$99.3K Sell
13,405
-16,465
-55% -$87.2K ﹤0.01% 2267
2025
Q2 		$135K Buy
29,870
+7,808
+35% +$34.8K ﹤0.01% 2212
2025
Q1 		$102K Sell
22,062
-1,168
-5% -$7.16K ﹤0.01% 2310
2024
Q4 		$161K Buy
23,230
+8,773
+61% +$65.8K ﹤0.01% 2092
2024
Q3 		$76.6K Buy
+14,457
New +$73K ﹤0.01% 1934

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's GLUE Position: Q2 2026 in Review

INTECH Investment Management reduced its Monte Rosa Therapeutics (GLUE) stake by 26% in Q2 2026, selling an estimated $94.4K and leaving 13,883 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

INTECH Investment Management first reported a position in GLUE in Q3 2024 and has held it in 8 quarters since. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • INTECH Investment Management held 13,883 shares of Monte Rosa Therapeutics worth $336K as of Q2 2026.
  • INTECH Investment Management sold 4,995 Monte Rosa Therapeutics shares in Q2 2026, an estimated $94.4K.
  • Monte Rosa Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1525 holding.
  • INTECH Investment Management first reported a position in Monte Rosa Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.